| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis.
|
Gastroenterology
|
2011
|
3.29
|
|
2
|
Nitroaspirin corrects immune dysfunction in tumor-bearing hosts and promotes tumor eradication by cancer vaccination.
|
Proc Natl Acad Sci U S A
|
2005
|
2.49
|
|
3
|
Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines.
|
Apoptosis
|
2006
|
0.94
|
|
4
|
Gastrointestinal-sparing effects of novel NSAIDs in rats with compromised mucosal defence.
|
PLoS One
|
2012
|
0.93
|
|
5
|
Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis.
|
Trends Pharmacol Sci
|
2009
|
0.93
|
|
6
|
Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell lines.
|
J Transl Med
|
2007
|
0.89
|
|
7
|
NO-donating aspirin and aspirin partially inhibit age-related atherosclerosis but not radiation-induced atherosclerosis in ApoE null mice.
|
PLoS One
|
2010
|
0.85
|
|
8
|
Efficacy of a nitric oxide-releasing nonsteroidal anti-inflammatory drug and cytotoxic drugs in human colon cancer cell lines in vitro and xenografts.
|
Mol Cancer Ther
|
2006
|
0.84
|
|
9
|
In vitro and in vivo evaluation of NCX 4040 cytotoxic activity in human colon cancer cell lines.
|
J Transl Med
|
2005
|
0.81
|
|
10
|
Nitrosulindac (NCX 1102): a new nitric oxide-donating non-steroidal anti-inflammatory drug (NO-NSAID), inhibits proliferation and induces apoptosis in human prostatic epithelial cell lines.
|
Prostate
|
2004
|
0.81
|
|
11
|
Antiproliferative effect of nitrosulindac (NCX 1102), a new nitric oxide-donating non-steroidal anti-inflammatory drug, on human bladder carcinoma cell lines.
|
Mol Cancer Ther
|
2004
|
0.79
|
|
12
|
Evaluation of the antitumoral potential of different nitric oxide-donating non-steroidal anti-inflammatory drugs (NO-NSAIDs) on human urological tumor cell lines.
|
Cancer Lett
|
2005
|
0.78
|
|
13
|
Prevention of bleomycin-induced lung fibrosis in mice by a novel approach of parallel inhibition of cyclooxygenase and nitric-oxide donation using NCX 466, a prototype cyclooxygenase inhibitor and nitric-oxide donor.
|
J Pharmacol Exp Ther
|
2012
|
0.78
|
|
14
|
Anti-inflammatory effects of nitric oxide-releasing hydrocortisone NCX 1022, in a murine model of contact dermatitis.
|
Br J Pharmacol
|
2004
|
0.78
|
|
15
|
NCX 4040, an NO-donating acetylsalicylic acid derivative: efficacy and mechanisms of action in cancer cells.
|
Nitric Oxide
|
2008
|
0.77
|